Skip to main content

Vaxzevria

Vaxzevria


Product Overview


Type:                         COVID-19 Vaccine (ChAdOx1-S ([recombinant])


INN:                           N/A


Trade name:             Vaxzevria


EUL holder:               AstraZeneca AB


Country:                    Sweden


Responsible NRA:    European Medicines Agency (EMA)


Country:                     The Netherlands


 

WHO EUL recommendation


Effective date:            15 April 2021


 

Product description


Pharmaceutical Form:                   Suspension for injection                                    


Presentation:                                   5 mL vial and 6 mL vial


Number of doses:                            8 doses (0.5 mL per dose) and 10 doses (0.5 mL per dose)


Route of administration:                Intramuscular


Age indication:                                18 years and older


Shelf – life:                                       9 months     Storage temperature:   2°C to 8°C      


Vaccine Vial monitor (VVM):        None


Preservative:                                    None


Adjuvant:                                           None


Diluent:                                               None


Handling of opened multi-dose vials: 

WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.


 

Packaging description

Secondary Packaging: 

 a. Carton of ten 5mL vials (80 doses). Dimensions: 8.1 x 4.1 x 10.6 cm.

 b. Carton of ten 10R vials (100 doses). Dimensions: 13.5 x 5.5 x 5.5 cm.

 c. Carton of ten 6mL vials (100 doses). Dimensions: 14.5 x 6.8 x 5.1 cm.

 d. Carton of ten 5mL vials (100 doses). Dimensions: 13.2 x 5.7 x 5.0 cm.

Tertiary Packaging: 

 a. 24 secondary packaged cartons containing 10 vials per carton (240 vials /1920 doses)  

     Dimensions: 26.2 x 22.8 x 18.8 cm

 b. 16 secondary packaged cartons containing 10 vials per carton (160 vials /1600 doses) 

     Dimensions: 29.0 x 25.0 x 13.1 cm

 c. 24 secondary packaged cartons containing 10 vials per carton (240 vials /2400 doses)

     Dimensions: 31.0 x 21.8 x 22.8 cm

 d. 24 secondary packaged cartons containing 10 vials per carton (240 vials /2400 doses)

     Dimensions: 24.8 x 28.8 x 18.0 cm

Cold Chain Volume in

secondary packaging:

 a. 4.40 cm3/dose      

 b. 4.08 cm3/dose      

 c. 5.03 cm3/dose      

 d. 3.76 cm3/dose      

 

Product Characteristics and Package Leaflet



Henogen S.A.
Rue de la Marlette 14, 7180 Seneffe, Belgium
 

Catalent Maryland, Inc
7555 Harmans Road Harmans, MD 21077, United States
 

Oxford Biomedica (UK) Ltd
Unit A Plot 7000 Alec Issigonis Way, Oxford OX4 2ZY, United Kingdom

Halix B.V.

Tinbergenweg 1, 2333 BB Leiden, Netherlands
 

WuXi Biologics
108 Meiliang Road, Mashan, Binhu District, WuXi, Jiangsu 214092, China

Amylin Ohio LLC (AZ)
8814 Trade Port Drive, West Chester, Ohio 45071, United States of America
 

Catalent Anagni
Località Fontana del Ceraso, S.P. Casilina, 41 03012 Anagni (FR), Italy
 

CP Pharmaceuticals
Ash Road North, Wrexham Industrial Estate, Wrexham LL13 9UF, United Kingdom
 

IDT Biologika
Am Pharmapark, Dessau-Rosslau 06861, Germany

Universal Farma, S.L. (“Chemo”)
C/Del Tejido, 2, Azugueca de Henares, Guadalajara, 19200, Spain